News & Blog Space

IOSH's June 2026 statement on MSD care puts prevention back at the centre of the debate. Here's how a structured, data-led risk assessment cycle answers that call. The UK government has put £3 million behind faster treatment for musculoskeletal disorders (MSDs). IOSH welcomed the funding, then asked, in the same breath, where prevention sits in the plan. The investment rolls NHS England's Getting It Right First Time (GIRFT) Musculoskeletal Community Delivery Programme out na

RSSB TFW MSD Case study shows how proactive risk management and system approach helps mitigate MSD risk factors

RSSB's T1278 research maps MSD risk across UK rail. How objective biomechanical data from TfW, LNER and Amey deployments turns its findings into action.RSSB's T1278 research maps MSD risk across UK rail. How objective biomechanical data from TfW, LNER and Amey deployments turns its findings into action.

SpatialCortex exhibited MOVA at VINCI's Innovation Inspiration Day on 24th June 2026, featured in the opening keynote. Insights on pilots, adoption, and MSD risk in construction.

SpatialCortex founder Kailash Manohara Selvan featured in IOSH Magazine on using AI wearable sensors to prevent musculoskeletal disorders in the workplace.

SpatialCortex attended the CIEHF Ergonomics & Human Factors Conference 2026, held 27th–29th April at the East Midlands Conference Centre, University of Nottingham. This is one of the UK's leading annual events for ergonomics and human factors professionals, bringing together researchers, practitioners, and industry leaders. Presented Paper: Understanding and Mitigating MSD Risks in Frontline Rail Staff Our research paper, "Understanding and Mitigating MSD Risks Faced by Front

How MOVA MMH delivers AI-driven manual handling risk assessments in food manufacturing, using HSE frameworks to reduce MSD risks.

The MOVA MMH pilot at LNER delivered four measurable outcomes: a 75% reduction in assessment time, validation against HSE MAC ratings, real-time risk threshold alerts, and cumulative full-shift exposure data — enabling evidence-based decision-making and ALARP compliance.